Pasithea Therapeutics (KTTA) insider Shahinian bought 88,901 shares for $100K at an average $1.13
Insider transactions reported
Eric Shahinian (insider at Pasithea Therapeutics Corp., KTTA) reported that they bought 88,901 shares for $100K at an average $1.13 between Sep 1, 2022 and Sep 6, 2022. After these transactions the filing shows 1,724,058 shares held indirectly (See footnote).
- Reporting person
- Shahinian Eric
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 1, 2022 | Open-market purchase (P) | Common Stock1 | +55,646 | $1.13 | $62.6K | 1,690,803 indirect |
| Sep 2, 2022 | Open-market purchase (P) | Common Stock1 | +11,507 | $1.14 | $13.1K | 1,702,310 indirect |
| Sep 6, 2022 | Open-market purchase (P) | Common Stock1 | +21,748 | $1.13 | $24.6K | 1,724,058 indirect |
Holdings before and after
- Common Stock: 1,635,157 to 1,724,058 indirect, See footnote
Footnotes from the filing
- 1. The shares are held by Camac Fund, LP. ( Camac Fund ). Eric Shahinian is the managing member of Camac Capital, LLC, which is the general partner of Camac Fund and the managing member of Camac Partners, LLC.
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Shahinian report in this KTTA Form 4?
Eric Shahinian (insider at Pasithea Therapeutics Corp., KTTA) reported that they bought 88,901 shares for $100K at an average $1.13 between Sep 1, 2022 and Sep 6, 2022. After these transactions the filing shows 1,724,058 shares held indirectly (See footnote).
How many KTTA shares does Shahinian hold after this filing?
The filing shows 1,724,058 shares held indirectly (See footnote) after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for KTTA
Earlier insider filings at KTTA
- Aug 31, 2022SEC Form 4: Shahinian Eric bought $26,293 worth of shares (22,828 units at $1.15)
- Aug 26, 2022SEC Form 4: Geller Avi bought $70,939 worth of shares (54,644 units at $1.30)
- Aug 18, 2022SEC Form 4: Shahinian Eric bought $188,283 worth of shares (155,773 units at $1.21)
- Jun 30, 2022SEC Form 4: Steinman Lawrence was granted 10,000 shares, increasing direct ownership by 0.79% to 1,272,174 units
- Jun 27, 2022SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.40% to 1,262,174 units
Keep researching KTTA
- KTTA insider tradesEvery buy and sale reported by Pasithea Therapeutics Corp. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- KTTA financial statementsRevenue, profit, cash flow and balance sheet from Pasithea Therapeutics Corp.'s SEC filings.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Follow KTTA and get a push notification the moment its next story breaks.